Quantum dots in imaging, drug delivery and sensor applications
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Quantum dots (QDs), also known as nanoscale semiconductor crystals, are nanoparticles with unique optical and electronic properties such as bright and intensive fluorescence. Since most conventional organic label dyes do not offer the near-infrared (>650 nm) emission possibility, QDs, with their tunable optical properties, have gained a lot of interest. They possess characteristics such as good chemical and photo-stability, high quantum yield and size-tunable light emission. Different types of QDs can be excited with the same light wavelength, and their narrow emission bands can be detected simultaneously for multiple assays. There is an increasing interest in the development of nano-theranostics platforms for simultaneous sensing, imaging and therapy. QDs have great potential for such applications, with notable results already published in the fields of sensors, drug delivery and biomedical imaging. This review summarizes the latest developments available in literature regarding the use of QDs for medical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, quantum sensors and imaging can aid in early disease detection (Matea et al., 2017; Tarasov et al., 2020).”
From Quantum technology for development framework as a tool for science diplomacy (2023) · cites this paper as Matea et al., 2017
Experimental — accuracy not yet measuredIn the citing paper
“QDs have been widely used in imaging and diagnostics. This is because emission from different QDs can be estimated simultaneously in a single assay using one wavelength.”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [111]
In the citing paper
“Recently there has been a lot of interest in developing theranostics application of QDs where simultaneous imaging, diagnosis and therapy is possible [111].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection
Chan, W. C. W., & Nie, S. (1998) · Science · doi:10.1126/science.281.5385.2016 · Cited by 7,278 · cited 2×
“One of the first reports of QDs (ZnS@CdSe) for ultrasensitive nonisotopic detection was published by Chan and Nie.(35) For the detection of the CA-125 serum biomarker in patients with ovarian cancer, Johari-Ahar et al proposed an impedimetric immunosensor that consisted of a mercaptopropionic acidmodified gold electro…”
A clearer vision for in vivo imaging
Weissleder, R. (2001) · Nature Biotechnology · doi:10.1038/86684 · Cited by 3,839
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
Kim, S., Lim, Y. T., Soltesz, E. G., De Grand, A. M., Lee, J., Nakayama, A., Parker, J. A., Mihaljevic, T., Laurence, R. G., Dor, D. M., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt920 · Cited by 2,087 · cited 1×
“Kim et al 11 proposed polydentate phosphine-coated QDs for major cancer surgery in large animals as a direct visual guidance throughout the entire sentinel lymph node mapping procedure, which permits a real-time confirmation of complete resection.”
Luminescent quantum dots for multiplexed biological detection and imaging
Chan, W. C. W., Maxwell, D. J., Gao, X., Bailey, R. E., Han, M., & Nie, S. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00282-3 · Cited by 2,068 · cited 1×
“59 There are a number of available methods ranging from non-covalent binding (electrostatic interactions 60 or biotin–avidin systems 4 ) to covalent binding (between amine and carboxylic acid groups, between aldehyde and hydrazine functions and between amino and sulfhydryl groups 61 ).”
Bioconjugated quantum dots for in vivo molecular and cellular imaging☆
SMITH, A., DUAN, H., MOHS, A., & NIE, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.015 · Cited by 1,193 · cited 6×
“This has prompted researchers to make use of the NIR optical window (700–1,700 nm) in order to conduct deep-tissue optical imaging with the aid of QDs. 9,10 A large number of formulations for QDs bio-imaging is currently available in literature.”
InfluentialKumar, A., Chowdhuri, A. R., Laha, D., Mahto, T. K., Karmakar, P., & Sahu, S. K. (2017) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2016.11.109 · Cited by 472
Core–shell quantum dots: Properties and applications
Vasudevan, D., Gaddam, R. R., Trinchi, A., & Cole, I. (2015) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2015.02.102 · Cited by 412 · cited 1×
“58 Other functionalization strategies in order to confer biological activity and low toxicity to QDs is to conjugate them to antibodies.”
pH-Sensitive ZnO Quantum Dots–Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery
Cai, X., Luo, Y., Zhang, W., Du, D., & Lin, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b04933 · Cited by 359
Simultaneous Multicolor Imaging of Five Different Lymphatic Basins Using Quantum Dots
Kobayashi, H., Hama, Y., Koyama, Y., Barrett, T., Regino, C. A. S., Urano, Y., & Choyke, P. L. (2007) · Nano Letters · doi:10.1021/nl0707003 · Cited by 332 · cited 1×
“Capped InP@ZnS QDs were used for cellular imaging by Kobayashi et al 12 in order to simultaneously visualize the draining of five separate lymphatic flows.”
Surface functionalization of quantum dots for biological applications
Karakoti, A. S., Shukla, R., Shanker, R., & Singh, S. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2014.11.004 · Cited by 316 · cited 1×
“7 In order to use QDs under ambient conditions, they must be stabilized or passivated, because of their high reactivity and surface area.”
Cited by
Controlled Drug Delivery Systems: Current Status and Future Directions
Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,691
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
“Due to their narrow emission, bright fluorescence, and high photo-stability, QDs can be used for tracking therapeutic agents within the cells/tissues [64,65].”
BackgroundSmart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998
“Quantum dots [154], fluorescent semiconducting nanocarriers, are often made of hundreds to thousands of atoms of group II and group VI molecule and have unique photophysical properties [155].”
BackgroundLombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
“Due to their fluorescence properties (which is intense and stable for a longer time), highly sensitive detection (high quantum yield and resistance to photobleaching), and size-tunable light emission, QDs are particularly suited for the development of a new class of biosensors used for cancer imaging and diagnosis [13…”
BackgroundMethodRecent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
“Recently there has been a lot of interest in developing theranostics application of QDs where simultaneous imaging, diagnosis and therapy is possible [111].”
BackgroundInnovative approaches for cancer treatment: current perspectives and new challenges
Pucci, C., Martinelli, C., & Ciofani, G. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.961 · Cited by 814
“Combined with active ingredients, they can be promising tools for theranostic applications [27].”
BackgroundToxicity of metal and metal oxide nanoparticles: a review
Sengul, A. B., & Asmatulu, E. (2020) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01033-6 · Cited by 681
Carbon quantum dots and their biomedical and therapeutic applications: a review
Molaei, M. J. (2019) · RSC Advances · doi:10.1039/c8ra08088g · Cited by 538
Metal-organic frameworks for advanced drug delivery
He, S., Wu, L., Li, X., Sun, H., Xiong, T., Liu, J., Huang, C., Xu, H., Sun, H., Chen, W., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.019 · Cited by 528
Quantum dots: Prospectives, toxicity, advances and applications
Gidwani, B., Sahu, V., Shukla, S. S., Pandey, R., Joshi, V., Jain, V. K., & Vyas, A. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102308 · Cited by 383
Quantum dots: Applications and safety consequences
Reshma, V. G., & Mohanan, P. V. (2019) · Journal of Luminescence · doi:10.1016/j.jlumin.2018.09.015 · Cited by 351
Nanotechnology-based antiviral therapeutics
Chakravarty, M., & Vora, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00818-0 · Cited by 334
Radiolabelling of nanomaterials for medical imaging and therapy
Pellico, J., Gawne, P. J., & T. M. de Rosales, R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00384k · Cited by 304
Biomedical Applications of Quantum Dots: Overview, Challenges, and Clinical Potential
Abdellatif, A. A., Younis, M. A., Alsharidah, M., Al Rugaie, O., & Tawfeek, H. M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s357980 · Cited by 284
“QDs in Biosensors; the Integration of Efficiency and Selectivity In addition to the above-mentioned applications, QDs have gained interest in the area of biosensors.(71) Biosensors are systems that can produce a measurable signal in response to the biological process in question.”
BackgroundCancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2020) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 255
Cui, L., Ren, X., Wang, J., & Sun, M. (2020) · Materials Today Nano · doi:10.1016/j.mtnano.2020.100091 · Cited by 236
Nanostructured carriers as innovative tools for cancer diagnosis and therapy
Martinelli, C., Pucci, C., & Ciofani, G. (2019) · APL Bioengineering · doi:10.1063/1.5079943 · Cited by 228
Dendrimer-Based Drug Delivery Systems for Brain Targeting
Zhu, Y., Liu, C., & Pang, Z. (2019) · Biomolecules · doi:10.3390/biom9120790 · Cited by 220
“5 nm) to turn down the cytotoxicity of QDs, improving its water solubility as well as quantum yield [175].”
BackgroundA review on advances of treatment modalities for Alzheimer's disease
Se Thoe, E., Fauzi, A., Tang, Y. Q., Chamyuang, S., & Chia, A. Y. Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119129 · Cited by 219
Phytochemical delivery through nanocarriers: a review
Ahmad, R., Srivastava, S., Ghosh, S., & Khare, S. K. (2021) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2020.111389 · Cited by 214
Recent Advances in Design of Fluorescence-Based Assays for High-Throughput Screening
Fang, X., Zheng, Y., Duan, Y., Liu, Y., & Zhong, W. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05303 · Cited by 208
Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems
Silva, C. O., Pinho, J. O., Lopes, J. M., Almeida, A. J., Gaspar, M. M., & Reis, C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11010022 · Cited by 210
“In the field of nanotheranostics, QDs are emerging as tools with high potential for such applications, demonstrated by several reports in the domains of drug delivery and biomedical imaging [159].”
BackgroundRecent Advances on Synthesis and Potential Applications of Carbon Quantum Dots
Magesh, V., Sundramoorthy, A. K., & Ganapathy, D. (2022) · Frontiers in Materials · doi:10.3389/fmats.2022.906838 · Cited by 204
“It has also been used for chemical sensing of heavy metal ions (Matea et al., 2017).”
Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies
Youf, R., Müller, M., Balasini, A., Thétiot, F., Müller, M., Hascoët, A., Jonas, U., Schönherr, H., Lemercier, G., Montier, T., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13121995 · Cited by 207
“up to 10 nm), QDs differ from other nano-objects with physical and optoelectronic properties governed by the rules of quantum mechanics, high chemical stability and resistance to photobleaching, and near-infrared (NIR) emission (typically above 700 nm) notably allowing for deep-tissue imaging [181].”
BackgroundMagne, T. M., de Oliveira Vieira, T., Alencar, L. M. R., Junior, F. F. M., Gemini-Piperni, S., Carneiro, S. V., Fechine, L. M. U. D., Freire, R. M., Golokhvast, K., Metrangolo, P., et al. (2022) · Journal of Nanostructure in Chemistry · doi:10.1007/s40097-021-00444-3 · Cited by 197
Belykh, E., Shaffer, K. V., Lin, C., Byvaltsev, V. A., Preul, M. C., & Chen, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00739 · Cited by 191
Toxicological status of nanoparticles: What we know and what we don't know
Missaoui, W. N., Arnold, R. D., & Cummings, B. S. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.015 · Cited by 191
“This combination has further limited the use of QDs in living systems, although these NPs have seen heavy use in the field of nanosensors and diagnostics [26].”
BackgroundAptamers used for biosensors and targeted therapy
Ning, Y., Hu, J., & Lu, F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110902 · Cited by 184
A Safe‐by‐Design Strategy towards Safer Nanomaterials in Nanomedicines
Yan, L., Zhao, F., Wang, J., Zu, Y., Gu, Z., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201805391 · Cited by 183
Kim, K., Lee, S., Jin, E., Palanikumar, L., Lee, J. H., Kim, J. C., Nam, J. S., Jana, B., Kwon, T.-H., Kwak, S. K., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05736 · Cited by 181
Nanocarriers based novel and effective drug delivery system
Khizar, S., Alrushaid, N., Alam Khan, F., Zine, N., Jaffrezic-Renault, N., Errachid, A., & Elaissari, A. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122570 · Cited by 171
Aptamer-based biosensor for detecting carcinoembryonic antigen
Xiang, W., Lv, Q., Shi, H., Xie, B., & Gao, L. (2020) · Talanta · doi:10.1016/j.talanta.2020.120716 · Cited by 170
Goshisht, M. K., & Tripathi, N. (2021) · Journal of Materials Chemistry C · doi:10.1039/d1tc01990b · Cited by 162
Redox-Responsive Drug Delivery Systems: A Chemical Perspective
Abed, H., Abuwatfa, W. H., & Husseini, G. A. (2022) · Nanomaterials · doi:10.3390/nano12183183 · Cited by 175
“Such nanoparticles include liposomes [4,9–11], micelles [12], denrimers [13], quantum dots [14], metal organic frameworks (MOFs) [15], polymeric systems [16], and many other nanoparticles.”
BackgroundSynthesis of CdS-modified chitosan quantum dots for the drug delivery of Sesamol
Abdelhamid, H. N., El-Bery, H. M., Metwally, A. A., Elshazly, M., & Hathout, R. M. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.03.024 · Cited by 162
Liu, P., Gao, C., Chen, H., Vong, C. T., Wu, X., Tang, X., Wang, S., & Wang, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.003 · Cited by 160
Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections
Wu, Y., Battalapalli, D., Hakeem, M. J., Selamneni, V., Zhang, P., Draz, M. S., & Ruan, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01132-8 · Cited by 152
Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
Zottel, A., Paska, A. V., & Jovčevska, I. (2019) · Materials · doi:10.3390/ma12101588 · Cited by 158
“Quantum dots can also be employed as a theranostic agent to carry drug and enable imaging simultaneously [53].”
BackgroundSamimi, S., Ardestani, M. S., & Dorkoosh, F. A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102287 · Cited by 142
Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
Thomas, O. S., & Weber, W. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00415 · Cited by 159
“The diversity of available nanoparticles for drug delivery is considerable and includes polymeric nanoparticles, dendrimers, carbon nanotubes, quantum dots, metallic nanoparticles or lipid-based systems, such as micelles or liposomes (Hughes, 2005; Cho et al., 2008; Bogart et al., 2014; Matea et al., 2017).”
BackgroundAn updated review of folate-functionalized nanocarriers: A promising ligand in cancer
Ebrahimnejad, P., Sodagar Taleghani, A., Asare-Addo, K., & Nokhodchi, A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.011 · Cited by 133
Nanomaterials: Synthesis and Applications in Theranostics
Paramasivam, G., Palem, V. V., Sundaram, T., Sundaram, V. A., Kishore, S. C., & Stefano Bellucci, A. (2021) · Nanomaterials · doi:10.3390/nano11123228 · Cited by 135
“QDs probes are made of semiconductor nanoparticles and are luminescent [74].”
BackgroundNanobiosensors: Point-of-care approaches for cancer diagnostics
Shandilya, R., Bhargava, A., Bunkar, N., Tiwari, R. R., Goryacheva, I. Y., & Mishra, P. K. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.01.034 · Cited by 143
Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
Vahedifard, F., & Chakravarthy, K. (2021) · Emergent Materials · doi:10.1007/s42247-021-00168-8 · Cited by 129
Advanced disease therapeutics using engineered living drug delivery systems
Mamidi, N., Silva, F. F. D., & Salehi, A. O. M. (2025) · Nanoscale · doi:10.1039/d4nr05298f · Cited by 139
Nanomaterials modified electrodes for electrochemical detection of Sudan I in food
Tajik, S., Orooji, Y., Ghazanfari, Z., Karimi, F., Beitollahi, H., Varma, R. S., Jang, H. W., & Shokouhimehr, M. (2021) · Journal of Food Measurement & Characterization · doi:10.1007/s11694-021-00955-1 · Cited by 126
“Of course, restriction of the electrons’ 3D movement resulted in an electronic configuration of QDs as the same as the configuration of atoms; thus, the QDs have been popular as the artificial atoms [62, 63].”
BackgroundRen, X., Zhang, F., Guo, B., Gao, N., & Zhang, X. (2019) · Nanomaterials · doi:10.3390/nano9040495 · Cited by 129
“, CQDs offer many advantages including good biocompatibility [4], robust chemical inertness [5], low toxicity [6], and outstanding optical properties [7], making them a promising carbon-based nanomaterial for applications such as biological sensing [8,9], bioimaging and photodynamic therapy [10–13], drug delivery [14]…”
I-III-VI core/shell QDs: Synthesis, characterizations and applications
Jain, S., Bharti, S., Bhullar, G. K., & Tripathi, S. K. (2019) · Journal of Luminescence · doi:10.1016/j.jlumin.2019.116912 · Cited by 125
Recent advances in nanotherapeutic strategies for spinal cord injury repair
Song, Y. H., Agrawal, N. K., Griffin, J. M., & Schmidt, C. E. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.011 · Cited by 130
Nano-based approach to combat emerging viral (NIPAH virus) infection
Kerry, R. G., Malik, S., Redda, Y. T., Sahoo, S., Patra, J. K., & Majhi, S. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.03.004 · Cited by 128
“94, 95 Mahajan et al showed that fluorescent quantum rods (QRs) a form of QD in conjugation with transferring, a targeting molecule and HAAT (Highly Active Antiretroviral Therapy) drug Sequinavir could freely cross an in vitro model of BBB.”
BackgroundJin, S., & Jin, H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110575 · Cited by 129
Tavan, M., Yousefian, Z., Bakhtiar, Z., Rahmandoust, M., & Mirjalili, M. H. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.121207 · Cited by 132
Nanoparticles in the diagnosis and treatment of vascular aging and related diseases
Xu, H., Li, S., & Liu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01082-z · Cited by 137
“QDs, which are fluorescent semiconductor nanoparticles, are made up of hundreds to a few thousand atoms.(49) Cores of QDs are only 2–10 nm in sizes, which can be replaced with AuNP or ION to mitigate long-term toxicities of QDs.”
BackgroundYang, L., Su, Q., Si, B., Zhang, Y., Zhang, Y., Yang, H., & Zhou, X. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.132230 · Cited by 115
Thiolated Nanoparticles for Biomedical Applications: Mimicking the Workhorses of Our Body
Hock, N., Racaniello, G. F., Aspinall, S. R., Denora, N., Khutoryanskiy, V. V., & Bernkop‐Schnürch, A. (2021) · Advanced Science · doi:10.1002/advs.202102451 · Cited by 118
Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine
Egwu, C. O., Aloke, C., Onwe, K. T., Umoke, C. I., Nwafor, J. A., Eyo, R. A., Chukwu, J. A., Ufebe, G. O., Ladokun, J., Audu, D. T., et al. (2024) · Molecules · doi:10.3390/molecules29112584 · Cited by 131
“Drugs such as 5-fluorouracil, doxorubicin, and paclitaxel loaded with QDs showed remarkable improvements in therapeutic outcomes [66].”
BackgroundReview of in vitro toxicological research of quantum dot and potentially involved mechanisms
Wang, Y., & Tang, M. X. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.12.334 · Cited by 111
Recent update of toxicity aspects of nanoparticulate systems for drug delivery
Patnaik, S., Gorain, B., Padhi, S., Choudhury, H., Gabr, G. A., Md, S., Mishra, D. K., & Kesharwani, P. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.02.010 · Cited by 116
Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
Wu, P., Opadele, A. E., Onodera, Y., & Nam, J. (2019) · Cancers · doi:10.3390/cancers11111783 · Cited by 112
“The introduction of QDs for biological and optical imaging was largely based on the ability to deliver these nanosized objects to cancer cells [134,135].”
BackgroundQuantum Dots and Their Interaction with Biological Systems
Le, N., Zhang, M., & Kim, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810763 · Cited by 121
Recent Breakthroughs in Using Quantum Dots for Cancer Imaging and Drug Delivery Purposes
Hamidu, A., Pitt, W. G., & Husseini, G. A. (2023) · Nanomaterials · doi:10.3390/nano13182566 · Cited by 125
“QDs have been widely used in various applications such as bioimaging, drug delivery, and diagnostics [125–130].”
MethodNanoparticles for drug delivery: Insight into in vitro and in vivo drug release from nanomedicines
Ewii, U. E., Attama, A. A., Olorunsola, E. O., Onugwu, A. L., Nwakpa, F. U., Anyiam, C. K., Chijioke, C., & Ogbulie, T. E. (2025) · Nano TransMed · doi:10.1016/j.ntm.2025.100083 · Cited by 139
Exploring Trends and Opportunities in Quantum‐Enhanced Advanced Photonic Illumination Technologies
Taha, B. A., Addie, A. J., Haider, A. J., Chaudhary, V., Apsari, R., Kaushik, A. K., & Arsad, N. (2024) · Advanced Quantum Technologies · doi:10.1002/qute.202300414 · Cited by 111
Ahmad, A., Mubarak, N. M., Naseem, K., Tabassum, H., Rizwan, M., Najda, A., Kashif, M., Bin-Jumah, M. N., Hussain, A., Shaheen, A., et al. (2020) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2020.10.019 · Cited by 107
Approved and marketed nanoparticles for disease targeting and applications in COVID-19
Abdellatif, A. A. H., & Alsowinea, A. F. (2021) · Nanotechnology Reviews · doi:10.1515/ntrev-2021-0115 · Cited by 115
“However, the medicinal use of QDs is still controversial [86,87].”
BackgroundRETRACTED: Vascular endothelial growth factor (VEGF) delivery approaches in regenerative medicine
Beheshtizadeh, N., Gharibshahian, M., Bayati, M., Maleki, R., Strachan, H., Doughty, S., & Tayebi, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115301 · Cited by 115
RetractedToxicity of different types of quantum dots to mammalian cells in vitro: An update review
Liu, N., & Tang, M. X. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.122606 · Cited by 100
Drug delivery systems based on nanoparticles and related nanostructures
Vujačić, A., Bondžić, A. M., & Vasić, V. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105412 · Cited by 108
Recent Advances in Second Near-Infrared Region (NIR-II) Fluorophores and Biomedical Applications
Chen, Y., Xue, L., Zhu, Q., Feng, Y., & Wu, M. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.750404 · Cited by 95
Different Methods and Formulations of Drugs and Vaccines for Nasal Administration
Tai, J., Han, M. S., Lee, D., Park, I., Lee, S. H., & Kim, T. H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051073 · Cited by 113
“Carbon quantum dots have a lower toxicity and better biocompatibility than gold and other semiconductor quantum dots [94].”
BackgroundZheng, J., Yue, R., Yang, R., Wu, Q., Wu, Y., Huang, M., Chen, X., Lin, W., Huang, J., Chen, X., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.940511 · Cited by 93
“Fluorescent quantum dots (QDs) can be rationally chosen as an alternative candidate because they have distinguishing optical properties including narrow-band and tunable fluorescence emission, high fluorescence quantum yields, and photostability (Matea et al., 2017; Pleskova et al., 2018).”
BackgroundNanotechnology-Based Strategies to Overcome Current Barriers in Gene Delivery
Mirón-Barroso, S., Domènech, E. B., & Trigueros, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168537 · Cited by 91
“On the other hand, QDs show several limitations: low aqueous solubility, complicated surface chemistry, low biological specificity, poorly controlled biodistribution to target tissues, and the potential for severe long-term toxicity [82,83].”
BackgroundRoss, S., Wu, R.-S., Wei, S., Ross, G. M., & Chang, H. (2020) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.1154 · Cited by 90
“modal imaging-associated cancer therapy [15-17].”
Quantum dots as targeted doxorubicin drug delivery nanosystems in human lung cancer cells
Ruzycka-Ayoush, M., Kowalik, P., Kowalczyk, A., Bujak, P., Nowicka, A. M., Wojewódzka, M., Kruszewski, M. K., & Grudziński, I. P. (2021) · Cancer Nanotechnology · doi:10.1186/s12645-021-00077-9 · Cited by 99
Quantum Dots: An Emerging Tool for Point-of-Care Testing
Singh, S., Dhawan, A., Karhana, S., Bhat, M., & Dinda, A. K. (2020) · Micromachines · doi:10.3390/mi11121058 · Cited by 102
“QDs application is evidence as excellent candidates for multimodal imaging probe and growing exponentially in medical as well in industry domain [128].”
BackgroundTak, K., Sharma, R., Dave, V., Jain, S., & Sharma, S. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00273 · Cited by 93
Fatima, M., Sheikh, A., Hasan, N., Sahebkar, A., Riadi, Y., & Kesharwani, P. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111156 · Cited by 89
Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review
Pathak, M. P., Pathak, K., Saikia, R., Gogoi, U., Ahmad, M. Z., Patowary, P., & Das, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112901 · Cited by 96
Bhavana, V., Thakor, P., Singh, S. B., & Mehra, N. K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118336 · Cited by 94
Photocatalytic nanoparticles – From membrane interactions to antimicrobial and antiviral effects
Parra‐Ortiz, E., & Malmsten, M. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102526 · Cited by 89
“In addition to antimicrobial effects due to either direct membrane destabilization or ROS-mediated oxidation on illumination, QDs are interesting for theranostic applications, where the same system can be used for inducing antimicrobial effects and for monitoring the effects of the treatment [15].”
BackgroundBhaladhare, S., & Bhattacharjee, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.12.076 · Cited by 86
Yanar, F., Carugo, D., & Zhang, X. (2023) · Molecules · doi:10.3390/molecules28155694 · Cited by 80
“Notably, QDs have an absorption wavelength higher than 650 nm in the near-infrared (NIR) region, which is advantageous in biomedical imaging applications as it presents minimal tissue absorption [44].”
BackgroundNanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment
Lemmerman, L. R., Das, D., Higuita‐Castro, N., Mirmira, R. G., & Gallego‐Perez, D. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.02.001 · Cited by 83
Dysfunction of various organelles provokes multiple cell death after quantum dot exposure
Wang, Y., & Tang, M. X. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s157135 · Cited by 80
“5,6 It has been reported that QDs can be used as probes for in vivo imaging.”
Site-specific drug delivery in the skin for the localized treatment of skin diseases
Chen, Y., Feng, X., & Meng, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1645119 · Cited by 79
“InP, GaAs, GaN) and so on, and the latter type is consisted of a core-type material embedded in another semiconductor with a large spectral bandgap [137].”
BackgroundLi, Z., Che, G., Jiang, W. H., Liu, L., & Wang, H. (2019) · RSC Advances · doi:10.1039/c9ra05600a · Cited by 80
Recent Advances and Challenges in Nanodelivery Systems for Antimicrobial Peptides (AMPs)
Tang, Z., Ma, Q., Chen, X., Chen, T., Ying, Y., Xi, X., Wang, L., Ma, C., Shaw, C., & Zhou, M. (2021) · Antibiotics · doi:10.3390/antibiotics10080990 · Cited by 85
Intelligent poly(l-histidine)-based nanovehicles for controlled drug delivery
Zhang, Y., Kim, I., Lu, Y., Xu, Y., Yu, D., & Song, W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.005 · Cited by 85
Pareek, A., Kumar, D., Pareek, A., & Gupta, M. M. (2025) · Cancers · doi:10.3390/cancers17050878 · Cited by 92
“QDs with amino groups are used for conjugation with peptides, proteins, receptors, and antibodies [67].”
Research advance on cell imaging and cytotoxicity of different types of quantum Dots
Huang, X., & Tang, M. X. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4083 · Cited by 78
Radionuclide‐Activated Nanomaterials and Their Biomedical Applications
Ferreira, C. A., Ni, D., Rosenkrans, Z. T., & Cai, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201900594 · Cited by 77
Mitochondrial toxicity of nanomaterials
Wu, D., Ma, Y., Cao, Y., & Zhang, T. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.134994 · Cited by 80
Carbon quantum dots derived from polysaccharides: Chemistry and potential applications
Emam, H. E. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121503 · Cited by 76
Radnia, F., Mohajeri, N., & Zarghami, N. (2019) · Talanta · doi:10.1016/j.talanta.2019.120547 · Cited by 72
Huang, Y., Cao, L., Parakhonskiy, B. V., & Skirtach, A. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050909 · Cited by 74
“However, several issues still need to be addressed in order to realize clinical applications of QD, such as overall toxicity, body clearance, scalability of synthetic protocols, environmental impact, and manufacturing costs [3,4].”
BackgroundMultifunctional theranostic nanoparticles for biomedical cancer treatments - A comprehensive review
Kandasamy, G., & Maity, D. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112199 · Cited by 73
Tian, J., Hu, J., Liu, G., Yin, H., Chen, M., Miao, P., Bai, P., & Yin, J. B. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.10.092 · Cited by 64
Targhan, H., Rezaei, A., Aliabadi, A., Zheng, H., Cheng, H., & Aminabhavi, T. M. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.148983 · Cited by 64
Introduction to cancer and treatment approaches
Chandraprasad, M. S., Dey, A., & Swamy, M. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90951-8.00010-2 · Cited by 102
Patil, T. S., & Deshpande, A. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.046 · Cited by 65
Metadata
- Authors
- Matea, C., Mocan, T., Tabaran, F., Pop, T., Mosteanu, O., Puia, C., Iancu, C., & Mocan, L.
- Affiliations
- Institutul Regional de Gastroenterologie Prof. Dr. Octavian Fodor (RO)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Corresponding author
- Mocan, Teodora
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2017-07
- Volume
- Volume 12
- Pages
- 5421-5431
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC5546783
- OpenAlex
- W2740839736
- Cited by
- 666
- References
- 58
- Citations by year
- 2026: 36 · 2025: 73 · 2024: 78 · 2023: 84 · 2022: 112 · 2021: 103 · 2020: 89 · 2019: 63 · 2018: 26 · 2017: 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Authority for Scientific Research and Innovation
- Autoritatea Natională pentru Cercetare Stiintifică
- Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (PN-II-PT-PCCA-2013, PN-III-P2-2.1-BG-2016-0446, PN-III-P2-2.1-PED-2016-1742, PN-II-RU-TE-2014-4-2267, PN-III-P2-2, PN-II-PT-PCCA-2013-4, PN-III-P2-2.1-PED-2016, PN-II-PT-PCCA-2013-4-1553)
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Quantum Dots Synthesis And Properties
- Physical Sciences › Materials Science › Materials Chemistry › Carbon and Quantum Dots Applications
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- quantum dots, semiconductor nanoparticles, fluorescence imaging, near-infrared emission, drug delivery, biosensors, theranostics, nanomedicine, photostability, tunable optical properties
- MeSH terms
- Animals, Bacteriological Techniques, Escherichia coli, Humans, Leishmania, Biosensing Techniques, Drug Delivery Systems, Quantum Dots, Nanoparticles, Molecular Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.